SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-046655
Filing Date
2020-10-16
Accepted
2020-10-16 15:53:13
Documents
1
Effectiveness Date
2020-10-16

Document Format Files

Seq Description Document Type Size
1 DEFA14A eypt-defa14a_20201201.htm DEFA14A 184789
  Complete submission text file 0001564590-20-046655.txt   186002
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-51122 | Film No.: 201243959
SIC: 3826 Laboratory Analytical Instruments